Small logo Subscribe to leading news on impact investing. Learn More
The Brief Originals Dealflow Signals The Impact Alpha Impact Voices Podcasts Agents of Impact Open
What's Next Capital on the Frontier Measure Better Investing in Racial Equity Beyond Trade-offs Impact en las Americas New Revivalists
Local and Inclusive Climate Finance Catalytic Capital Frontier Finance Best Practices Geographies
Slack Agent of Impact Calls Events Contribute
The Archive ImpactSpace The Accelerator Selection Tool Network Map
About Us FAQ Calendar Pricing and Payment Policy Privacy Policy Terms of Service Agreement Contact Us
Locavesting Entrepreneurship Gender Smart Return on Inclusion Good Jobs Creative economy Opportunity Zones Investing in place Housing New Schooled Well Being People on the Move Faith and investing Inclusive Fintech
Clean Energy Farmer Finance Soil Wealth Conservation Finance Financing Fish
Innovative Finance
Personal Finance Impact Management
Africa Asia Europe Latin America Middle East Oceania/Australia China Canada India United Kingdom United States
Subscribe
Features
Series
Themes
Community
Data
Subscribe Log In
More

Acquisition Gives Investors’ Circle Big Exit



Concerned about the shortage of exit opportunities for impact investments?

Here’s one: Early-stage impact investing network Investors’ Circle announced an exit from its portfolio this week, as Boston Heart Diagnostics, a US-based health services firm with a proprietary blood test was acquired by Luxembourg-based Eurofins Scientific for  $140 million.

“We were compelled by the social mission of saving lives, the well-conceived business model, and an attractive valuation,” said Sky Lance, Investors’ Circle member and managing principal of the Patient Capital Collaborative fund. Investors’ Circle has deployed $185 million into more than 290 companies.

You might also like...